Can drug repurposing uncover better treatments for UTIs?
Growing antibiotic resistance and chronic urinary tract infections have illustrated the need for new, effective treatments for UTIs.
Drug Development
FDA grants EUA to Lilly’s Covid-19 antibody therapy for paediatric use
The EUA has been granted based on safety and efficacy data from the BLAZE-1 trial...
Recordati to acquire EUSA Pharma to expand rare disease products portfolio
EUSA Pharma’s product portfolio includes Qarziba, Sylvant, Fotivda and Caphosol.
UCB and Novartis to co-develop two drug candidates for Parkinson’s Disease
UCB and Novartis will jointly fund and manage the future clinical development of the drugs.
Narrow FDA panel vote on Merck’s molnupiravir bolsters outlook on mAbs
A close FDA committee vote to authorize molnupiravir indicates that mAbs could still be favored...
UK’s MHRA grants authorisation for GSK-Vir Biotechnology’s Covid-19 drug
MHRA has recommended the use of GSK and Vir Biotechnology’s Xevudy within five days from the start of Covid-19 symptoms.
Astellas and Dyno Therapeutics to develop AAV gene therapy vectors
Dyno will design the new AAV capsids with improved functional properties for gene therapy.
Marathon Asset Management to acquire pharmaceutical firm Kaléo for $310m
Kaléo currently markets the AUVI-Q 0.15mg and 0.3mg, as well as the AUVI-q 0.1mg injections.
EC grants approval for Merck-Eisai’s combo therapy for endometrial cancer
The approval is based on positive data from the Phase III KEYNOTE-775/Study 309 trial of Keytruda plus Lenvima.
Link Health to obtain global rights for Bone Therapeutics’ cell therapy
The new agreement is in addition to the deal entered last year to develop and market ALLOB.
Enzychem and Cadila collaborate to produce Covid-19 vaccine in Korea
The partnership between Enzychem and Cadila is expected to manufacture 80 million or more doses of the vaccine next year.
